J.P. Morgan Provides $35MM Revolving Credit Agreement to Meitheal Pharmaceuticals
Meitheal Pharmaceuticals, a fully integrated generic injectables company based in Chicago, entered into a $35 million senior secured revolving credit agreement with J.P. Morgan.
August 23, 2023
J.P. Morgan | Meitheal Pharmaceuticals | Tom Shea
Ian Koplin